decentralized clinical trials

Understanding the Role of Patient Feasibility in the Planning of Decentralized Trials

About Since the onset of Covid, have Decentralized Clinical Trials lived up to their potential, and where do the principal challenges for DCT lie today? Join us for an intriguing exploration with one of the leading figures in Decentralized Trials, Craig Lipset, alongside Maya Zlatanova, a pioneer in integrating innovative …

Understanding the Role of Patient Feasibility in the Planning of Decentralized Trials Read More »

the importance of patient centricity in decentralized trials

The Future of Patient-Centricity in Clinical Research: How Decentralized Clinical Trials Are Revolutionizing Participant Experience

Imagine a world where participating in clinical research is as simple and unobtrusive as a routine check-up. Decentralized Clinical Trials (DCTs) have the potential to do that if they put the patient at the center when planning their trials. In this blog, we’ll unravel how DCTs are not just a …

The Future of Patient-Centricity in Clinical Research: How Decentralized Clinical Trials Are Revolutionizing Participant Experience Read More »

Clinical Research in Poland: Excellent Recruitment and DCT Adoption

Lukasz Wozniak joined the industry in 2005 working for CRO companies. He has been working independently since 2010 as a freelance clinical trial consultant contracted by pharmaceutical and CRO companies covering CRA and regulatory affairs positions. Overall, Lukasz has 16 years of experience in research and in recent years, he …

Clinical Research in Poland: Excellent Recruitment and DCT Adoption Read More »

The Benefits of Conducting a Clinical Trial in Spain

María López is a freelance clinical research consultant and part of TrialHub’s network of country advisors. She has 25 years of experience in clinical research both in medical devices and drug clinical studies. Over the years she has held different positions: field clinical monitor, clinical research associate, clinical trial manager, …

The Benefits of Conducting a Clinical Trial in Spain Read More »

Decentralized Clinical Trial Regulations: A 2022 Report

Decentralization in clinical trials is quickly turning into a must-have for companies that truly want to support patients, provide more convenience and reach recruitment goals. Decentralized clinical trials (DCTs) hold the potential to reach new, remote patient populations, innovate rare and orphan disease research, and accelerate medical discovery.  In order …

Decentralized Clinical Trial Regulations: A 2022 Report Read More »

Our 5 Most Valued Clinical Trial Resources – 2021 on the Blog

The end of the year is near and naturally, we all become retrospective. 2021 was a difficult year for most of us, despite the scientific progress that gave us hope. Yet, even difficult years come with a lot of lessons and many opportunities for growth.  This year, instead of counting …

Our 5 Most Valued Clinical Trial Resources – 2021 on the Blog Read More »

The One Thing Your Decentralized Clinical Trial Strategy Is Missing

Recently, Maya Zlatanova’s article Decentralized Clinical Trials Across Europe: Regulatory and Other Practical Considerations was published in DIA’s Global Forum. The piece highlights the most important considerations for planning and conducting decentralized clinical trials in Europe – from the different ‘readings’ of EMA’s guidelines depending on the country to the mindset of the patients depending …

The One Thing Your Decentralized Clinical Trial Strategy Is Missing Read More »

Regional Considerations of Decentralized Clinical Trials

Last Friday, I participated in a very interesting talk on Clubhouse about the Regional Considerations of Decentralized Trials hosted by the people with probably the most experience in the space – Craig Lipset and Amir Kalali from DTRA and Mark Campbell. The organizers and speakers did a great job outlining some of the regional hurdles to planning …

Regional Considerations of Decentralized Clinical Trials Read More »

How Decentralized Trials Can Support Continuity of Operations

In Part 7 of the Webinar “How Research Sites Can Win With Decentralized Trials” the panelists discuss leadership and technology in DCTs: Panelists Raymond Nomizu from Clinical Research IO, a site-centered electronic Source and CTMS solution;Edye T. Edens, Senior Research Compliance Consultant at First Class Solutions; Daniel Perez, Chief Operating Officer at MACRO Trials – a Site Optimization …

How Decentralized Trials Can Support Continuity of Operations Read More »

What Kind of Leadership Do Decentralized Trials Call For?

In Part 6 of the Webinar “How Research Sites Can Win With Decentralized Trials” the panelists discuss leadership and technology in DCTs: Panelists Raymond Nomizu from Clinical Research IO, a site-centered electronic Source and CTMS solution;Edye T. Edens, Senior Research Compliance Consultant at First Class Solutions; Daniel Perez, Chief Operating Officer at MACRO Trials – a Site Optimization …

What Kind of Leadership Do Decentralized Trials Call For? Read More »

Scroll to Top